Lupin Limited has received an Environmental, Social and Governance (ESG) rating of 67 from ESG Risk Assessments & Insights Limited, positioning the pharmaceutical company in the Strong category. The company disclosed this development to stock exchanges on January 19, 2026, in compliance with regulatory requirements.

ESG Rating Details

The assessment was conducted independently by ESG Risk Assessments & Insights Limited without any direct engagement from Lupin. The rating agency prepared its evaluation based entirely on publicly available company data and information in the public domain.

Regulatory Compliance

Lupin made the disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was sent to both the National Stock Exchange of India Limited and BSE Limited as part of the company's ongoing compliance obligations.

The disclosure was signed by Amit Kumar Gupta, Company Secretary & Compliance Officer, emphasizing the company's commitment to transparency in ESG-related developments. The independent nature of the assessment highlights that Lupin did not commission or influence the rating process.

Market Significance

The Strong category ESG rating reflects positively on Lupin's environmental, social, and governance practices. ESG ratings have become increasingly important for investors and stakeholders in evaluating companies' sustainability performance and long-term value creation potential. The rating of 67 demonstrates Lupin's performance across various ESG parameters as assessed through publicly available information.

Lupin Limited has issued a postal ballot notice seeking shareholder approval for the appointment of Mr. Anand Kripalu as Independent Director. The pharmaceutical company's Board of Directors had previously approved his appointment as Additional Director (Non-Executive, Independent) effective February 01, 2026, during their meeting held on January 06, 2026.

Postal Ballot Notice Details

The company issued the postal ballot notice on January 14, 2026, to stock exchanges BSE Limited and National Stock Exchange of India Limited. The notice outlines the voting process and timeline for shareholder approval:

Board Appointment Framework

Mr. Kripalu's appointment was made based on the recommendation of the Nomination and Remuneration Committee. The appointment details include:

Professional Background and Expertise

Mr. Anand Kripalu brings over three decades of extensive industry experience in the fast-moving consumer goods sector. His distinguished career includes:

• Current Role: Executive Director of EPL Limited (previously Managing Director and Global CEO until December 31, 2025)
• Previous Leadership Positions: MD & CEO of Diageo India, President of India and South-East Asia at Mondelez International (Cadbury)
• Early Career: More than 20 years at Unilever in various general management, sales and marketing roles

Educational Qualifications and Current Directorships

Mr. Kripalu holds an MBA from IIM, Calcutta, and B. Tech (Electronics) from IIT Madras. He has completed the Advanced Management Program from Wharton Business School and received Distinguished Alumnus Awards from both IIM and IIT.

He currently serves as Independent Director at:

• Swiggy Limited
• United Breweries Limited
• PGP Glass Private Limited

Voting Process and Compliance

The postal ballot will be conducted exclusively through remote e-voting facility provided by NSDL. Members whose names appear in the Register of Members as on the cut-off date of January 09, 2026, are eligible to vote. The company has appointed Mr. Saurabh Agarwal or Ms. Deepti Kulkarni from M/s. Makarand M. Joshi & Co., Practicing Company Secretaries, as Scrutinizers for the voting process.

Lupin Limited confirmed that Mr. Kripalu is not debarred from holding the office of Director by SEBI or any other authority and is not related to any Directors, Key Managerial Personnel, or Promoters of the Company.